Breaking News Instant updates and real-time market news.

AVXS

AveXis

$211.85

0.68 (0.32%)

, NVS

Novartis

$80.91

-0.96 (-1.17%)

05:19
04/12/18
04/12
05:19
04/12/18
05:19

AveXis downgraded to Neutral from Buy at UBS

UBS analyst Carter Gould downgraded AveXis (AVXS) to Neutral while raising his price target for the shares to $218 from $143. The analyst has confidence the takeover by Novartis (NVS) will close, and notes the shares are within 5% of the $218 offer price. The chance of antitrust concerns arising are remote, Gould tells investors in a research note.

AVXS

AveXis

$211.85

0.68 (0.32%)

NVS

Novartis

$80.91

-0.96 (-1.17%)

  • 23

    Apr

  • 17

    May

  • 05

    Jun

AVXS AveXis
$211.85

0.68 (0.32%)

04/11/18
FBCO
04/11/18
DOWNGRADE
Target $218
FBCO
Neutral
AveXis downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Martin Auster downgraded AveXis (AVXS) to Neutral from Outperform and raised his price target on the shares to $218 from $170 ahead of likely closing of the Novartis (NVS) deal.
04/10/18
SBSH
04/10/18
DOWNGRADE
SBSH
Neutral
AveXis downgraded to Neutral from Buy at Citi
CIit analyst Mohit Bansa downgraded AveXis (AVXS) following the company's agreement to be acquired by Novartis (NVS). The analyst in late January called AveXis an "interesting" takeover target. His buyout valuation was $185 per share without extra credit to the pipeline and $250 per share when including a 25% probability to Rhett and 25% extra probability to spinal muscular atrophy type 2. Novartis is buying the company for $218 per share or $8.7B in cash.
04/10/18
JEFF
04/10/18
NO CHANGE
JEFF
Jefferies sees value in Abeona, Sangamo, Ultragenyx after AveXis deal
Jefferies analyst Maury Raycroft believes Novartis' (NVS) acquisition of AveXis (AVXS) provides additional validation for the progress and potential of gene therapy. The deal brings attention to Abeona Therapeutics (ABEO) specifically, based on the company's use of AAV9, which is the same vector AveXis has been evaluating with its lead program AVXS-101, Raycroft tells investors in a research note. He thinks yesterday's takeover puts an updated value on gene therapy, implying long-term potential and "sufficient de-risking has occurred." The analyst feels the premium paid for AveXis shows value in Abeona, Sangamo (SGMO) and Ultragenyx (RARE).
04/10/18
BERN
04/10/18
NO CHANGE
Target $318
BERN
Outperform
Acquisition of AveXis increases pressure on Biogen Spinraza, says Bernstein
Bernstein analyst Aaron Gal believes that Biogen (BIIB) odds of counter-bidding Novartis (NVS) takeout offer for AveXis (AVXS) are low, primarily because of FTC concerns. Nonetheless, the analyst notes that this increases pressure on Biogen's Spinraza as it puts the competing SMA program in the hands of a well-funded, payer-competent, global-reaching company. Gal reiterates an Outperform rating and $318 price target on Biogen's shares.
NVS Novartis
$80.91

-0.96 (-1.17%)

04/09/18
MSCO
04/09/18
DOWNGRADE
MSCO
Equal Weight
AveXis downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst David Lebowitz downgraded AveXis (AVXS) to Equal Weight from Overweight following its announcement of an agreement to be acquired by Novartis (NVS) for $218 per share. He added that the buyout premium AveXis garnered should benefit Regenxbio (RGNX) as well.

TODAY'S FREE FLY STORIES

OXM

Oxford Industries

$84.74

(0.00%)

09:41
11/21/18
11/21
09:41
11/21/18
09:41
Periodicals
Breaking Periodicals news story on Oxford Industries »

Oxford Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.10

(0.00%)

, GPS

Gap

$24.65

(0.00%)

09:40
11/21/18
11/21
09:40
11/21/18
09:40
Options
Unusually active option classes on open November 21st »

Unusual total active…

FL

Foot Locker

$46.10

(0.00%)

GPS

Gap

$24.65

(0.00%)

MT

ArcelorMittal

$23.41

(0.00%)

ADSK

Autodesk

$122.99

(0.00%)

WLL

Whiting Petroleum

$28.78

(0.00%)

SLV

iShares Silver Trust

$13.45

(0.00%)

DE

Deere

$138.49

(0.00%)

FXI

iShares China Large-Cap ETF

$40.18

(0.00%)

WDC

Western Digital

$45.69

(0.00%)

M

Macy's

$31.96

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 26

    Nov

  • 27

    Nov

  • 04

    Dec

  • 04

    Dec

  • 03

    Mar

09:40
11/21/18
11/21
09:40
11/21/18
09:40
General news
U.S. Existing Home Sales Preview »

U.S. Existing Home Sales…

PULM

Pulmatrix

$0.39

-0.0205 (-5.05%)

09:36
11/21/18
11/21
09:36
11/21/18
09:36
Hot Stocks
Pulmatrix says objectives from Phase 1/1b study of Pulmazole 'successfully met' »

Pulmatrix, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

ROST

Ross Stores

$82.65

-8.54 (-9.37%)

09:35
11/21/18
11/21
09:35
11/21/18
09:35
Recommendations
Ross Stores analyst commentary  »

Ross Stores price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:35
11/21/18
11/21
09:35
11/21/18
09:35
General news
U.S. Michigan Consumer Sentiment Preview »

U.S. Michigan Consumer…

TGT

Target

$69.05

-8.08 (-10.48%)

09:34
11/21/18
11/21
09:34
11/21/18
09:34
Recommendations
Target analyst commentary  »

Target price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

ANAB

AnaptysBio

$68.73

0.8 (1.18%)

09:32
11/21/18
11/21
09:32
11/21/18
09:32
Initiation
AnaptysBio initiated  »

JPMorgan sees attractive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.10

-2.69 (-5.51%)

, NKE

Nike

$71.13

-1.39 (-1.92%)

09:30
11/21/18
11/21
09:30
11/21/18
09:30
Recommendations
Foot Locker, Nike analyst commentary  »

Foot Locker price target…

FL

Foot Locker

$46.10

-2.69 (-5.51%)

NKE

Nike

$71.13

-1.39 (-1.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

CS

Credit Suisse

$11.72

-0.585 (-4.75%)

09:30
11/21/18
11/21
09:30
11/21/18
09:30
Downgrade
Credit Suisse rating change  »

Credit Suisse downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 27

    Nov

09:30
11/21/18
11/21
09:30
11/21/18
09:30
General news
The U.S. durables report undershot estimates »

The U.S. durables report…

GPS

Gap

$24.65

-0.79 (-3.11%)

09:26
11/21/18
11/21
09:26
11/21/18
09:26
Recommendations
Gap analyst commentary  »

Gap price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

ADI

Analog Devices

$89.12

3.57 (4.17%)

09:25
11/21/18
11/21
09:25
11/21/18
09:25
Recommendations
Analog Devices analyst commentary  »

Analog Devices price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

TMUS

T-Mobile

$66.56

-1.45 (-2.13%)

, S

Sprint

$6.08

-0.11 (-1.78%)

09:25
11/21/18
11/21
09:25
11/21/18
09:25
Periodicals
T-Mobile shifts approach to selling Sprint merger to regulators, Bloomberg says »

T-Mobile (TMUS), in a…

TMUS

T-Mobile

$66.56

-1.45 (-2.13%)

S

Sprint

$6.08

-0.11 (-1.78%)

T

AT&T

$29.41

-0.93 (-3.07%)

VZ

Verizon

$59.46

-1.17 (-1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 26

    Nov

  • 03

    Dec

  • 04

    Dec

QCOM

Qualcomm

$54.92

0.02 (0.04%)

, AAPL

Apple

$177.10

-8.7 (-4.68%)

09:23
11/21/18
11/21
09:23
11/21/18
09:23
Periodicals
Qualcomm gets Apple's patent claims dismissed, Bloomberg reports »

Qualcomm (QCOM) won bid…

QCOM

Qualcomm

$54.92

0.02 (0.04%)

AAPL

Apple

$177.10

-8.7 (-4.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

ECOL

US Ecology

$70.69

-1.29 (-1.79%)

09:19
11/21/18
11/21
09:19
11/21/18
09:19
Recommendations
US Ecology analyst commentary  »

US Ecology price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$65.06

-7.9 (-10.83%)

09:18
11/21/18
11/21
09:18
11/21/18
09:18
Recommendations
Jacobs Engineering analyst commentary  »

Jacobs Engineering price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 19

    Feb

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
11/21/18
11/21
09:18
11/21/18
09:18
Options
Overnight activity included 663 trades in SPX and 38 trades in VIX »

663 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGCO

Agco

$57.86

0.5 (0.87%)

09:16
11/21/18
11/21
09:16
11/21/18
09:16
Recommendations
Agco analyst commentary  »

William Blair keeps…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSS

Kohl's

$64.45

-6.3 (-8.90%)

09:15
11/21/18
11/21
09:15
11/21/18
09:15
Recommendations
Kohl's analyst commentary  »

Kohl's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECOL

US Ecology

$70.69

-1.29 (-1.79%)

09:11
11/21/18
11/21
09:11
11/21/18
09:11
Hot Stocks
US Ecology sees FY18 at lower end of prior guidance after Grand View explosion »

In a regulatory 8-K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZOES

Zoe's Kitchen

$12.75

(0.00%)

09:09
11/21/18
11/21
09:09
11/21/18
09:09
Hot Stocks
Breaking Hot Stocks news story on Zoe's Kitchen »

Zoes Kitchen trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COLD

Americold Realty Trust

$26.11

-0.27 (-1.02%)

09:05
11/21/18
11/21
09:05
11/21/18
09:05
Recommendations
Americold Realty Trust analyst commentary  »

Americold Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:05
11/21/18
11/21
09:05
11/21/18
09:05
General news
Treasury Action: Treasury yields have slipped from earlier highs »

Treasury Action: Treasury…

TGP

Teekay LNG

$12.79

-0.77 (-5.68%)

09:04
11/21/18
11/21
09:04
11/21/18
09:04
Recommendations
Teekay LNG analyst commentary  »

Teekay LNG price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.